Connect with us

Technology

NB Bancorp, Inc. Reports Second Quarter 2026 Financial Results, Declares Quarterly Cash Dividend

Published

on

NEEDHAM, Mass., July 22, 2026 /PRNewswire/ — NB Bancorp, Inc. (the “Company”) (Nasdaq Capital Market: NBBK), the holding company of Needham Bank (the “Bank”), today announced its second quarter 2026 financial results.

Net income for the second quarter of 2026 amounted to $21.1 million, or $0.53 per diluted common share, compared to net income of $15.0 million, or $0.36 per diluted common share, for the prior quarter. Return on average assets and return on average equity for the second quarter of 2026 were 1.17% and 10.03%, respectively, increases from 0.87% and 7.05%, respectively, for the prior quarter.Operating net income(1) for the second quarter of 2026 increased 38.5% and amounted to $21.9 million, or $0.55 per diluted common share, compared to operating net income(1) of $15.8 million, or $0.38 per diluted common share, for the prior quarter. Operating return on average assets(1) and operating return on average equity(1) for the second quarter of 2026 were 1.21% and 10.39%, respectively, increases from 0.92% and 7.43%, respectively, for the prior quarter.Net interest margin expanded by 7 basis points to 4.00% from 3.93% in the prior quarter as total loans increased 3.4% while total deposits increased 3.7% during the quarter. Net interest margin, excluding purchase accounting adjustments(1), expanded by 5 basis points to 3.87% during the current quarter from 3.82% in the prior quarter.Efficiency ratio improved to 58.92% from 61.55% in the prior quarter, while operating efficiency ratio(1) improved to 57.66% from 60.06% in the prior quarter.Net charge-offs (annualized) as a percent of average loans declined to 0.07% from 0.91% in the prior quarter. Non-performing loans as a percent of total loans decreased to 0.43% at the end of the second quarter from 0.73% at the end of the prior quarter.

“The second quarter of 2026 displayed Needham Bank’s continued execution of our strategy for disciplined growth in market share as total loans increased 3.4% during the quarter, while total deposits increased 3.7% over the same period. Through the first half of 2026, total loans and total deposits have increased by 15.0% and 15.9% on an annualized basis, while operating EPS increased 24%, respectively. Our teams remained focused on executing our strategic priorities and investing in the infrastructure, technology, and operating capabilities needed to support continued profitable growth. This included targeted investments in artificial intelligence, improved internal systems and automation tools designed to enhance internal efficiency, scalability, and employee effectiveness. We are well positioned to continue to enhance the customer experience and grow market share, while improving long-term operating leverage. The dedication and collaboration of our employees continue to be defining strengths for Needham Bank. As we invest thoughtfully in technology, artificial intelligence, and operational capabilities, while maintaining strong credit performance and disciplined growth, we are building a more scalable and efficient organization that is well-positioned to deliver long-term value for our customers, communities, and shareholders,” Campanelli concluded.

Declaration of Dividend
The Board of Directors declared a quarterly cash dividend of $0.07 per share, payable on August 19, 2026, to shareholders of record as of August 5, 2026.

SELECTED FINANCIAL HIGHLIGHTS FOR THE SECOND QUARTER OF 2026

Net income of $21.1 million, or $0.53 per diluted common share, compared to net income of $15.0 million, or $0.36 per diluted common share, for the prior quarter. Operating net income(1), excluding one-time charges, amounted to $21.9 million, or $0.55 per diluted common share, compared to operating net income(1) of $15.8 million, or $0.38 per diluted common share, for the prior quarter.Operating return on average assets increased to 1.21% from 0.92%, operating return on average equity increased to 10.39% from 7.43% and net interest margin expanded to 4.00% from 3.93%.Credit trends from the BankProv acquisition improved during the quarter, where net charge-offs to average loans decreased to 0.07% from 0.91% and non-performing assets to total assets decreased to 0.37% from 0.63%

One-time pre-tax charges during the current quarter include:

Non-recurring fees for business line expansion of $649 thousand ($499 thousand net of tax);Final merger and acquisition costs of $296 thousand ($227 thousand net of tax) related to the Company’s acquisition of Provident; andTax expense and a modified endowment contract penalty of $27 thousand related to the surrender of Bank-owned life insurance (“BOLI”) policies acquired from BankProv.

One-time pre-tax charges during the prior quarter include:

Pre-tax trailing merger and acquisition costs of $534 thousand ($390 thousand net of tax) related to the Company’s completed acquisition of Provident;Non-recurring fees for business line expansion of $500 thousand ($366 thousand net of tax); andTax expense and a modified endowment contract penalty of $50 thousand related to the surrender of BOLI policies acquired from BankProv.Net interest margin expanded by 7 basis points to 4.00% during the current quarter from 3.93% in the prior quarter. Net interest margin, excluding purchase accounting adjustments(1), expanded by 5 basis points to 3.87% during the current quarter from 3.82% in the prior quarter.Gross loans increased $213.0 million, or 3.4%, to $6.42 billion, from $6.21 billion in the prior quarter.Total deposits increased $222.9 million, or 3.7%, to $6.32 billion, from $6.10 billion in the prior quarter.Core deposits, which the Company considers to be all non-brokered deposits, increased $73.1 million, or 1.3%, to $5.60 billion, from $5.53 billion in the prior quarter.Brokered deposits increased $149.8 million, or 26.3%, to $719.9 million, from $570.1 million in the prior quarter.Book value per share and tangible book value per share(1) were $19.22 and $18.51, respectively, in the current quarter, compared to $18.83 and $18.11, respectively, in the prior quarter. The increase in tangible book value per share(1) was a result of $21.1 million in net income for the quarter, partially offset by the repurchase of 918,727 shares during the current quarter at an all-in weighted average cost of $20.13 per share and $3.1 million in dividends paid during the quarter.

BALANCE SHEET
Total assets amounted to $7.45 billion as of June 30, 2026, representing an increase of $220.2 million, or 3.0%, from $7.23 billion as of March 31, 2026.

Cash and cash equivalents increased $24.6 million, or 6.5%, to $400.2 million from $375.6 million in the prior quarter, as a result of net income earned during the quarter of $21.1 million, along with deposit growth of $222.9 million, partially offset by loan growth of $211.1 million and the repurchase of 918,727 shares during the current quarter at an all-in weighted average cost of $20.13 per share.Net loans increased $211.1 million, or 3.4%, to $6.34 billion, from $6.13 billion in the prior quarter as demand for new loan originations and advances continued. The current quarter change was primarily seen in commercial real estate loans, which increased $196.7 million, or 10.2%, residential real estate loans, which increased $45.0 million, or 3.4%, and multi-family residential loans, which increased $29.6 million, or 5.5%, partially offset by mortgage warehouse loans, which decreased $59.5 million, or 21.5% along with continued run-off of the acquired Enterprise Value portfolio, which decreased $29.5 million, or 18.5%, from the prior quarter.Deposits increased $222.9 million, or 3.7%, to $6.32 billion from $6.10 billion in the prior quarter. The change in deposits was the result of noninterest bearing demand deposits, which increased $80.8 million, or 9.3%, NOW accounts, which increased $61.8 million, or 8.9% and brokered deposits, which increased $149.8 million, or 26.3%, partially offset by money market accounts, which decreased $77.4 million, or 4.4%.Shareholders’ equity decreased $776 thousand, or 0.1%, to $842.0 million, from $842.8 million in the prior quarter, primarily as a result of the repurchase of 918,727 shares of common stock at an all-in weighted average cost of $20.13 per share totaling $18.5 million and $3.1 million in dividends paid during the current quarter, partially offset by net income of $21.1 million. Shareholders’ equity to total assets and tangible shareholders’ equity(1) to tangible assets were 11.3% and 10.9%, respectively, at the end of the current quarter, compared to 11.7% and 11.3%, respectively, at the end of the prior quarter.

NET INTEREST INCOME
Net interest income increased $4.3 million, or 6.6%, to $69.1 million for the current quarter, compared to $64.9 million for the prior quarter. Net interest margin expanded 7 basis points to 4.00% for the current quarter, from 3.93% in the prior quarter.

Interest income increased during the current quarter, primarily attributable to an increase in the average balance of and weighted average rate on loans as a result of the continued execution of our growth strategy, partially offset by a reduction in the average balance of and weighted average rate on short-term investments.Interest expense increased for the current quarter, primarily driven by increases in the average balances of certificates of deposit and individual retirement accounts and FHLB borrowings, partially offset by a decrease in the weighted average rate on certificates of deposit and individual retirement accounts.

PROVISION FOR CREDIT LOSSES
Provision for credit losses decreased $3.1 million, or 49.5%, to a provision for credit losses of $3.2 million for the current quarter, compared to a provision for credit losses of $6.3 million for the prior quarter.

The provision for credit losses on loans decreased $3.4 million, or 53.1%, to $3.0 million for the current quarter, compared to $6.4 million for the prior quarter, primarily driven by an $822 thousand recovery from a commercial and industrial loan, improved qualitative factors on commercial real estate and multi-family loans and no downgrades in qualitative factors, which existed in the prior quarter.The provision for credit losses on unfunded commitments increased $253 thousand, or 468.5%, to $199 thousand for the current quarter, compared to a release of $54 thousand for the prior quarter, primarily driven by an increase in net unfunded commitments in the current quarter.

NONINTEREST INCOME
Noninterest income increased $1.0 million, or 23.2%, to $5.6 million for the current quarter, compared to $4.5 million for the prior quarter.

Customer service fees increased $550 thousand, or 17.6%, to $3.7 million for the current quarter, compared to $3.1 million in the prior quarter due to increased loan fee income, cash management fees and customer transactional volume.Other income increased $315 thousand, or 150.0%, to $525 thousand for the current quarter, compared to $210 thousand in the prior quarter, primarily driven by $229 thousand of credit card branding and marketing income recognized during the quarter, along with higher preferred dividends from solar tax credit investments.Gain (loss) on sale of loans, net, increased $228 thousand to a $227 thousand gain in the current quarter, compared to a $1 thousand loss in the prior quarter, resulting from the improvement in the fair market value of consumer loans held for sale during the current quarter.

NONINTEREST EXPENSE
Noninterest expense increased $1.3 million, or 3.1%, to $44.0 million for the current quarter, compared to $42.7 million for the prior quarter.

Marketing and charitable contribution expenses increased $497 thousand, or 48.1%, to $1.5 million for the current quarter, compared to $1.0 million for the prior quarter, primarily resulting from advertising expenses related to customer events and branch openings, as well as a higher volume of Bank contributions to charities during the current quarter.Data processing expenses increased $460 thousand, or 10.4%, to $4.9 million for the current quarter, compared to $4.4 million for the prior quarter, primarily driven by our continued investment in technology and systems in support of upcoming revenue initiatives, requiring the operation of systems in parallel for a period of time while new systems are implemented.FDIC and state insurance assessment expenses increased $432 thousand, or 37.5%, to $1.6 million for the current quarter, compared to $1.2 million for the prior quarter, primarily driven by increased insurance assessments related to the BankProv acquisition.

INCOME TAXES
Income tax expense increased $1.0 million, or 18.7%, to $6.4 million for the current quarter, compared to $5.4 million for the prior quarter. The increase was primarily driven by the increase in net income during the current quarter. The effective tax rate and the operating effective tax rate(1) were 23.2% and 23.1%, respectively, for the current quarter, compared to 26.4% and 26.2%, respectively, for the prior quarter. The primary drivers of the decrease in the effective tax rate were a higher volume of earned income tax credits and tax-exempt interest income on loans due to the origination of a tax-exempt loan at the end of the prior quarter.

COMMERCIAL REAL ESTATE PORTFOLIO
Commercial real estate loans increased $226.2 million, or 9.2%, to $2.69 billion, during the current quarter.

Cannabis facility commercial real estate loans decreased $3.7 million, or 1.7%, to $210.1 million during the current quarter. The Company’s cannabis facility commercial real estate portfolio is secured entirely by the underlying commercial real estate of the borrower operation, in addition to, in most cases, a lien on all business assets. The vast majority of the cannabis facility loan portfolio balances have a loan-to-value ratio of 65% or lower, with appraisal reports taking a blended approach (using both cannabis and non-cannabis use comparable real estate sales, which we believe are generally more conservative).The cannabis facility portfolio has geographic dispersion, with lower dollar exposure loans remaining local and larger dollar exposure loans generally tied to multi-state operators with a more national footprint. All cannabis facility loan relationships were current at the end of the current quarter.The Company’s multi-family real estate loan portfolio increased $29.6 million, or 5.5%, during the current quarter to $567.7 million. The Company’s multi-family real estate loan portfolio consists of properties primarily located in the Greater Boston area, all of which are adjustable-rate loans and performing at the end of the current quarter.The Company’s $335.7 million office portfolio consists principally of suburban Class A and B office space used as medical and traditional offices. The portfolio does not consist of high-rise towers located in Boston and are performing at the end of the current quarter.

ASSET QUALITY

The allowance for credit losses (“ACL”) amounted to $82.1 million as of June 30, 2026, or 1.28% of total loans, compared to $80.2 million, or 1.29% of total loans as of March 31, 2026.The Company recorded a provision for credit losses of $3.2 million during the current quarter, which included a provision for credit losses on loans of $3.0 million and a provision of $199 thousand for unfunded commitments, compared to a provision for credit losses of $6.3 million during the prior quarter, which included a provision for credit losses on loans of $6.4 million and a release of provision of $54 thousand for unfunded commitments.The increase in the ACL for the current quarter was primarily driven by loan growth.Non-performing loans (“NPLs”) decreased $17.9 million, or 39.3%, to $27.7 million as of June 30, 2026, from $45.6 million at the end of the prior quarter. The decrease was primarily due to the decrease in commercial and industrial loans on non-accrual of $18.4 million, resulting from improved performance or workouts. The ACL as a percent of NPLs is 297% as of June 30, 2026, an increase from 176% at the end of the prior quarter.During the current quarter, the Company recorded total net charge-offs of $1.1 million, or 0.07% of average total loans on an annualized basis, which related to non-purchase-credit-deteriorated (“PCD”) loans, compared to net charge-offs of $13.6 million, or 0.91% of average total loans on an annualized basis, in the prior quarter. The $12.4 million decrease in net charge-offs during the current quarter was primarily a result of prior quarter charge-offs on previously fully reserved for PCD commercial and industrial loans. As part of its ongoing credit risk management framework and prudent oversight, the Company periodically reviews lending relationships across all portfolios to ensure alignment with its risk appetite, regulatory expectations, and evolving market conditions.The Company’s loan portfolio consists primarily of commercial real estate and multi-family loans, one-to-four-family residential real estate loans, construction and land development loans, commercial and industrial loans, mortgage warehouse loans and consumer loans. These loans are primarily made to individuals and businesses located in our primary lending market area, which is the Greater Boston metropolitan area and surrounding communities in greater New England.

(1)

Represents a non-GAAP measure. See Non-GAAP reconciliation of the corresponding GAAP measures on pages 13 and 14.

ABOUT NB BANCORP, INC.
NB Bancorp, Inc. (Nasdaq Capital Market: NBBK) is the registered bank holding company of Needham Bank. Needham Bank is headquartered in Needham, Massachusetts, which is approximately 17 miles southwest of Boston’s financial district. Known as the “Builder’s Bank,” Needham Bank has been helping individuals, businesses and non-profits build for their futures since 1892. Needham Bank offers an array of tech-forward products and services that businesses and consumers use to manage their financial needs. Needham Bank also provides services to companies in the cannabis industry by providing loans and deposits, along with supporting payment platforms in this industry, such as Mosaic.

We have the financial expertise typically found at much larger institutions and the local knowledge and commitment you can only find at a community bank. For more information, please visit https://NeedhamBank.com. Needham Bank is a member of FDIC.

Non-GAAP Financial Measures 
In addition to results presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”), this press release contains certain non-GAAP financial measures, including pre-provision net revenue, operating net income, operating pre-tax income, net interest margin, excluding purchase accounting adjustments, operating noninterest expense, operating noninterest income, operating effective tax rate, operating earnings per share, basic, operating earnings per share, diluted, operating return on average assets, operating return on average shareholders’ equity, operating efficiency ratio, tangible shareholders’ equity, tangible assets and tangible book value per share. The Company’s management believes that the supplemental non-GAAP information is utilized by regulators and market analysts to evaluate a Company’s financial condition and therefore, such information is useful to investors. These disclosures should not be viewed as a substitute for financial results determined in accordance with GAAP, nor are they necessarily comparable to non-GAAP performance measures that may be presented by other companies. Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures with other companies’ non-GAAP financial measures having the same or similar names.

Forward-Looking Statements
Statements in this press release that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

We may also make forward-looking statements in other documents we file with the Securities and Exchange Commission (the “SEC”), in our annual reports to our stockholders, in press releases and other written materials, and in oral statements made by our officers, directors or employees. You can identify forward-looking statements by the use of the words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “assume,” “outlook,” “will,” “should,” and other expressions that predict or indicate future events and trends and which do not relate to historical matters. Although the Company believes that these forward-looking statements are based on reasonable estimates and assumptions, they are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors. You should not place undue reliance on our forward-looking statements. You should exercise caution in interpreting and relying on forward-looking statements because they are subject to significant risks, uncertainties and other factors which are, in some cases, beyond the Company’s control. The Company’s actual results could differ materially from those projected in the forward-looking statements as a result of, among other factors, changes in general business and economic conditions on a national basis and in the local markets in which the Company operates, including changes which adversely affect borrowers’ ability to service and repay loans; changes in customer behavior due to political, business and economic conditions, including inflation and concerns about liquidity; turbulence in the capital and debt markets; reductions in net interest income resulting from interest rate volatility as well as changes in the balances and mix of loans and deposits; changes in interest rates and real estate values; changes in loan collectability and increases in defaults and charge-off rates; decreases in the value of securities and other assets, adequacy of credit loss reserves, or deposit levels necessitating increased borrowing to fund loans and investments; risks related to the Company’s acquisitions generally, including disruption to current plans and operations; difficulties in customer and employee retention; fees, expenses and charges related to these transactions being significantly higher than anticipated; unforeseen integration issues or impairment of other intangibles; and the Company’s inability to achieve expected revenues, cost savings, synergies, and other benefits at levels or within the timeframes originally anticipated; changing government regulation; competitive pressures from other financial institutions; changes in legislation or regulation and accounting principles, policies and guidelines; cybersecurity incidents, fraud, natural disasters, and future pandemics; the risk that the Company may not be successful in the implementation of its business strategy; the risk that intangibles recorded in the Company’s financial statements will become impaired; changes in assumptions used in making such forward-looking statements; and the other risks and uncertainties detailed in the Company’s Form 10-K and updated by our Quarterly Report on Form 10-Q and other filings submitted to the SEC. These statements speak only as of the date of this release and the Company does not undertake any obligation to update or revise any of these forward-looking statements to reflect events or circumstances occurring after the date of this communication or to reflect the occurrence of unanticipated events.

NB BANCORP, INC.

SELECTED FINANCIAL HIGHLIGHTS

(Unaudited)

(Dollars in thousands, except per share data)

As of and for the three months ended

June 30, 2026

March 31, 2026

June 30, 2025

Earnings data

   Net interest income

$

69,145

$

64,868

$

47,007

   Noninterest income

5,559

4,513

4,278

   Total revenue

74,704

69,381

51,285

   Provision for credit losses

3,193

6,328

3,161

   Noninterest expense

44,017

42,701

29,405

   Pre-tax income

27,494

20,352

18,719

   Net income

21,123

14,984

14,579

   Operating net income (non-GAAP)

21,877

15,791

15,043

   Operating noninterest expense (non-GAAP)

43,072

41,667

28,875

Per share data

   Earnings per share, basic

$

0.53

$

0.37

$

0.39

   Earnings per share, diluted

0.53

0.36

0.39

   Operating earnings per share, basic (non-GAAP)

0.55

0.39

0.40

   Operating earnings per share, diluted (non-GAAP)

0.55

0.38

0.40

   Book value per share

19.22

18.83

18.09

   Tangible book value per share (non-GAAP)

18.51

18.11

18.07

Profitability

   Return on average assets

1.17 %

0.87 %

1.13 %

   Operating return on average assets (non-GAAP)

1.21 %

0.92 %

1.16 %

   Return on average shareholders’ equity

10.03 %

7.05 %

7.84 %

   Operating return on average shareholders’ equity (non-GAAP)

10.39 %

7.43 %

8.09 %

   Net interest margin

4.00 %

3.93 %

3.82 %

   Net interest margin, excluding purchase accounting adjustments

3.87 %

3.82 %

3.82 %

   Cost of deposits

2.68 %

2.73 %

3.00 %

   Efficiency ratio

58.92 %

61.55 %

57.34 %

   Operating efficiency ratio (non-GAAP)

57.66 %

60.06 %

56.30 %

Balance sheet, end of period

   Total assets

$

7,446,880

$

7,226,649

$

5,226,618

   Total loans

6,482,821

6,273,881

4,540,969

   Total deposits

6,320,090

6,097,200

4,268,115

   Total shareholders’ equity

842,002

842,778

737,122

Asset quality

   ACL

$

82,088

$

80,195

$

42,601

   ACL / Total NPLs

296.8 %

176.0 %

341.4 %

   Total NPLs / Total loans

0.43 %

0.73 %

0.27 %

   Annualized net charge-offs / Average total loans

(0.07) %

(0.91) %

0.00 %

Capital ratios

   Shareholders’ equity / Total assets

11.31 %

11.66 %

14.10 %

   Tangible shareholders’ equity / tangible assets (non-GAAP)

10.94 %

11.27 %

14.09 %

 

NB BANCORP, INC.

CONSOLIDATED BALANCE SHEETS

(Unaudited)

(Dollars in thousands, except share and per share data)

As of

June 30, 2026 change from

June 30, 2026

March 31, 2026

June 30, 2025

March 31, 2026

June 30, 2025

Assets

Cash and due from banks

$

372,522

$

327,951

$

157,175

$

44,571

13.6 %

$

215,347

137.0 %

Federal funds sold

27,632

47,618

101,587

(19,986)

(42.0) %

(73,955)

(72.8) %

   Total cash and cash equivalents

400,154

375,569

258,762

24,585

6.5 %

141,392

54.6 %

Available-for-sale securities, at fair value

272,640

277,241

235,408

(4,601)

(1.7) %

37,232

15.8 %

Loans held for sale, at fair value

59,927

63,971

–

(4,044)

(6.3) %

59,927

0.0 %

Loans receivable, net of deferred fees

6,422,894

6,209,910

4,540,969

212,984

3.4 %

1,881,925

41.4 %

Allowance for credit losses

(82,088)

(80,195)

(42,601)

(1,893)

2.4 %

(39,487)

92.7 %

   Net loans

6,340,806

6,129,715

4,498,368

211,091

3.4 %

1,842,438

41.0 %

Accrued interest receivable

28,898

27,150

20,386

1,748

6.4 %

8,512

41.8 %

Banking premises and equipment, net

49,298

47,335

34,289

1,963

4.1 %

15,009

43.8 %

Non-public investments

42,029

40,738

35,767

1,291

3.2 %

6,262

17.5 %

Bank-owned life insurance (“BOLI”)

97,370

110,586

55,711

(13,216)

(12.0) %

41,659

74.8 %

Prepaid expenses and other assets

69,228

67,749

57,277

1,479

2.2 %

11,951

20.9 %

Goodwill

18,512

18,512

–

–

0.0 %

18,512

0.0 %

Core deposit intangible, net

17,519

18,411

1,005

(892)

(4.8) %

16,514

1643.2 %

Deferred income tax asset, net

50,499

49,672

29,645

827

1.7 %

20,854

70.3 %

   Total assets

$

7,446,880

$

7,226,649

$

5,226,618

$

220,231

3.0 %

$

2,220,262

42.5 %

Liabilities and shareholders’ equity

Deposits

Core deposits

$

5,600,238

$

5,527,148

$

4,013,955

$

73,090

1.3 %

$

1,586,283

39.5 %

Brokered deposits

719,852

570,052

254,160

149,800

26.3 %

465,692

183.2 %

Total deposits

6,320,090

6,097,200

4,268,115

222,890

3.7 %

2,051,975

48.1 %

Mortgagors’ escrow accounts

4,420

4,858

4,117

(438)

(9.0) %

303

7.4 %

Federal Home Loan Bank (“FHLB”) borrowings

181,247

189,701

127,600

(8,454)

(4.5) %

53,647

42.0 %

Accrued expenses and other liabilities

77,549

70,983

68,235

6,566

9.3 %

9,314

13.6 %

Accrued retirement liabilities

21,572

21,129

21,429

443

2.1 %

143

0.7 %

   Total liabilities

6,604,878

6,383,871

4,489,496

221,007

3.5 %

2,115,382

47.1 %

Shareholders’ equity:

Preferred stock, $0.01 par value, 5,000,000 shares authorized; no shares

   issued and outstanding

–

–

–

–

0.0 %

–

0.0 %

Common stock, $0.01 par value, 120,000,000 shares authorized; 43,818,490 issued and

outstanding at June 30, 2026, 44,765,178 issued and outstanding at March 31, 2026

and 40,748,380 issued and outstanding at June 30, 2025

438

448

407

(10)

(2.2) %

31

7.6 %

Additional paid-in capital

415,841

432,858

358,793

(17,017)

(3.9) %

57,048

15.9 %

Unallocated common shares held by the Employee Stock Ownership Plan (“ESOP”)

(41,285)

(41,873)

(43,643)

588

(1.4) %

2,358

(5.4) %

Retained earnings

474,970

456,978

427,707

17,992

3.9 %

47,263

11.1 %

Accumulated other comprehensive loss

(7,962)

(5,633)

(6,142)

(2,329)

41.3 %

(1,820)

29.6 %

   Total shareholders’ equity

842,002

842,778

737,122

(776)

(0.1) %

104,880

14.2 %

   Total liabilities and shareholders’ equity

$

7,446,880

$

7,226,649

$

5,226,618

$

220,231

3.0 %

$

2,220,262

42.5 %

 

NB BANCORP, INC.

CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(Dollars in thousands, except share and per share data)

Three Months Ended June 30, 2026

For the Three Months Ended

 Change From Three Months Ended

June 30, 2026

March 31, 2026

June 30, 2025

March 31, 2026

June 30, 2025

INTEREST AND DIVIDEND INCOME

Interest and fees on loans

$

106,574

$

100,042

$

74,719

$

6,532

6.5 %

$

31,855

42.6 %

Interest on securities

2,758

2,708

2,307

50

1.8 %

451

19.5 %

Interest and dividends on cash equivalents and other

2,460

2,936

2,822

(476)

(16.2) %

(362)

(12.8) %

   Total interest and dividend income

111,792

105,686

79,848

6,106

5.8 %

31,944

40.0 %

INTEREST EXPENSE

Interest on deposits

40,686

39,579

31,690

1,107

2.8 %

8,996

28.4 %

Interest on borrowings

1,961

1,239

1,151

722

58.3 %

810

70.4 %

   Total interest expense

42,647

40,818

32,841

1,829

4.5 %

9,806

29.9 %

NET INTEREST INCOME

69,145

64,868

47,007

4,277

6.6 %

22,138

47.1 %

PROVISION FOR CREDIT LOSSES

Provision for credit losses – loans

2,994

6,382

4,244

(3,388)

(53.1) %

(1,250)

(29.5) %

Provision for (release of) credit losses – unfunded commitments

199

(54)

(1,083)

253

468.5 %

1,282

(118.4) %

   Total provision for credit losses

3,193

6,328

3,161

(3,135)

(49.5) %

32

1.0 %

NET INTEREST INCOME AFTER

PROVISION FOR CREDIT LOSSES

65,952

58,540

43,846

7,412

12.7 %

22,106

50.4 %

NONINTEREST INCOME

Customer service fees

3,681

3,131

2,554

550

17.6 %

1,127

44.1 %

Increase in cash surrender value of BOLI

962

853

787

109

12.8 %

175

22.2 %

Mortgage banking income

92

119

120

(27)

(22.7) %

(28)

(23.3) %

Swap contract income

72

201

524

(129)

(64.2) %

(452)

(86.3) %

Gain (loss) on sale of loans, net

227

(1)

21

228

22800.0 %

206

981.0 %

Other income

525

210

272

315

150.0 %

253

93.0 %

   Total noninterest income

5,559

4,513

4,278

1,046

23.2 %

1,281

29.9 %

NONINTEREST EXPENSE

Salaries and employee benefits

25,549

25,468

18,567

81

0.3 %

6,982

37.6 %

Director and professional service fees

3,816

4,049

2,943

(233)

(5.8) %

873

29.7 %

Occupancy and equipment expenses

2,468

2,491

1,465

(23)

(0.9) %

1,003

68.5 %

Data processing expenses

4,899

4,439

2,493

460

10.4 %

2,406

96.5 %

Marketing and charitable contribution expenses

1,530

1,033

954

497

48.1 %

576

60.4 %

FDIC and state insurance assessments

1,584

1,152

883

432

37.5 %

701

79.4 %

General and administrative expenses

4,171

4,069

2,100

102

2.5 %

2,071

98.6 %

   Total noninterest expense

44,017

42,701

29,405

1,316

3.1 %

14,612

49.7 %

INCOME BEFORE TAXES

27,494

20,352

18,719

7,142

35.1 %

8,775

46.9 %

INCOME TAX EXPENSE

6,371

5,368

4,140

1,003

18.7 %

2,231

53.9 %

NET INCOME

$

21,123

$

14,984

$

14,579

$

6,139

41.0 %

$

6,544

44.9 %

Weighted average common shares outstanding, basic

39,693,140

40,969,748

37,191,460

(1,276,608)

(3.1) %

2,501,680

6.7 %

Weighted average common shares outstanding, diluted

40,000,305

41,421,002

37,550,409

(1,420,697)

(3.4) %

2,449,896

6.5 %

Earnings per share, basic

$

0.53

$

0.37

$

0.39

$

0.16

43.2 %

$

0.14

35.9 %

Earnings per share, diluted

$

0.53

$

0.36

$

0.39

$

0.17

47.2 %

$

0.14

35.9 %

 

NB BANCORP, INC.

AVERAGE BALANCES, INTEREST EARNED/PAID & AVERAGE YIELDS

(Unaudited)

(Dollars in thousands)

For the Three Months Ended

June 30, 2026

March 31, 2026

June 30, 2025

Average 

Average 

Average 

Outstanding 

Average 

Outstanding 

Average 

Outstanding 

Average 

Balance

Interest

Yield/Rate (4)

Balance

Interest

Yield/Rate (4)

Balance

Interest

Yield/Rate (4)

Interest-earning assets:

Loans (5)

$

6,377,025

$

106,574

6.70

%

$

6,090,227

$

100,042

6.66

%

$

4,479,479

$

74,719

6.69

%

Securities

279,196

2,758

3.96

%

273,308

2,708

4.02

%

232,812

2,307

3.97

%

Other investments (5)

34,301

612

7.16

%

28,275

265

3.80

%

28,525

605

8.51

%

Short-term investments (5)

237,667

1,848

3.12

%

295,394

2,671

3.67

%

200,524

2,217

4.43

%

Total interest-earning assets

6,928,189

111,792

6.47

%

6,687,204

105,686

6.41

%

4,941,340

79,848

6.48

%

Non-interest-earning assets

394,611

375,966

277,915

Allowance for credit losses

(81,276)

(88,102)

(39,931)

Total assets

$

7,241,524

$

6,975,068

$

5,179,324

Interest-bearing liabilities:

Savings accounts

$

210,544

324

0.62

%

$

207,681

263

0.51

%

$

119,736

134

0.45

%

NOW accounts

701,167

2,265

1.30

%

639,347

2,006

1.27

%

469,472

1,259

1.08

%

Money market accounts

1,699,366

12,783

3.02

%

1,711,672

12,732

3.02

%

1,090,163

9,062

3.33

%

Certificates of deposit and individual retirement accounts

2,595,290

25,314

3.91

%

2,497,213

24,578

3.99

%

1,964,678

21,235

4.34

%

Total interest-bearing deposits

5,206,367

40,686

3.13

%

5,055,913

39,579

3.17

%

3,644,049

31,690

3.49

%

FHLB borrowings

209,002

1,961

3.76

%

135,441

1,239

3.71

%

103,406

1,151

4.46

%

Total interest-bearing liabilities

5,415,369

42,647

3.16

%

5,191,354

40,818

3.19

%

3,747,455

32,841

3.52

%

Non-interest-bearing deposits

883,487

824,839

593,136

Other non-interest-bearing liabilities

98,225

97,370

93,063

Total liabilities

6,397,081

6,113,563

4,433,654

Shareholders’ equity

844,443

861,505

745,670

Total liabilities and shareholders’ equity

$

7,241,524

$

6,975,068

$

5,179,324

Net interest income

$

69,145

$

64,868

$

47,007

Net interest rate spread (1)

3.31

%

3.22

%

2.96

%

Net interest-earning assets (2)

$

1,512,820

$

1,495,850

$

1,193,885

Net interest margin (3)

4.00

%

3.93

%

3.82

%

Average interest-earning assets to interest-bearing liabilities

127.94

%

128.81

%

131.86

%

(1)

Net interest rate spread represents the difference between the weighted average yield on interest-earning assets and the weighted average rate of interest-bearing liabilities.

(2)

Net interest-earning assets represent total interest-earning assets less total interest-bearing liabilities.

(3)

Net interest margin represents net interest income divided by average total interest-earning assets.

(4)

Annualized.

(5)

Loans include loans held for sale, at fair value. Other investments are comprised of Federal Reserve Bank stock, FHLB stock and swap collateral accounts. Short-term investments are comprised of cash and cash equivalents.

 

NB BANCORP, INC.

COMMERCIAL REAL ESTATE BY COLLATERAL TYPE

(Unaudited)

(Dollars in thousands)

June 30, 2026

Owner-Occupied

Non-Owner-Occupied

Balance

Percentage

Multi-Family

$

—

$

567,722

$

567,722

20 %

Industrial

185,270

163,112

348,382

13 %

Office

44,635

291,110

335,745

12 %

Hospitality

41,266

247,242

288,508

11 %

Mixed-Use

22,408

225,392

247,800

9 %

Retail

126,323

109,201

235,524

9 %

Cannabis Facility

201,153

8,913

210,066

8 %

Special Purpose

84,655

69,837

154,492

6 %

Recreational Vehicle Parks

13,255

65,162

78,417

3 %

Self Storage Facilities

—

71,147

71,147

3 %

Other

87,282

64,164

151,446

6 %

Total commercial real estate

$

806,247

$

1,883,002

$

2,689,249

100 %

Change From March 31, 2026

Change From June 30, 2025

Owner-Occupied

Non-Owner-Occupied

Balance

Percentage

Owner-Occupied

Non-Owner-Occupied

Balance

Percentage

Multi-Family

$

—

$

29,558

$

29,558

5 %

$

—

$

250,977

$

250,977

79 %

Industrial

55,111

6,772

61,883

22 %

98,479

50,105

148,584

74 %

Office

2,706

(2,552)

154

0 %

18,478

110,801

129,279

63 %

Hospitality

1,996

(11,711)

(9,715)

(3) %

41,266

75,083

116,349

68 %

Mixed-Use

(922)

24,693

23,771

11 %

14,765

65,014

79,779

47 %

Retail

73,112

(5,164)

67,948

41 %

86,769

22,358

109,127

86 %

Cannabis Facility

(3,613)

(85)

(3,698)

(2) %

(54,604)

(6,185)

(60,789)

(22) %

Special Purpose

(2,298)

8,159

5,861

4 %

6,535

12,860

19,395

14 %

Recreational Vehicle Parks

(125)

13,159

13,034

20 %

13,255

65,162

78,417

100 %

Self Storage Facilities

—

(16,443)

(16,443)

(19) %

—

71,147

71,147

100 %

Other

38,079

15,791

53,870

55 %

47,462

9,372

56,834

60 %

Total commercial real
estate

$

164,046

$

62,177

$

226,223

9 %

$

272,405

$

726,694

$

999,099

59 %

March 31, 2026

June 30, 2025

Owner-Occupied

Non-Owner-Occupied

Balance

Percentage

Owner-Occupied

Non-Owner-Occupied

Balance

Percentage

Multi-Family

$

—

$

538,164

$

538,164

21 %

$

—

$

316,745

$

316,745

19 %

Industrial

130,159

156,340

286,499

12 %

86,791

113,007

199,798

12 %

Office

41,929

293,662

335,591

13 %

26,157

180,309

206,466

12 %

Hospitality

39,270

258,953

298,223

12 %

—

172,159

172,159

10 %

Mixed-Use

23,330

200,699

224,029

9 %

7,643

160,378

168,021

10 %

Retail

53,211

114,365

167,576

7 %

39,554

86,843

126,397

7 %

Cannabis Facility

204,766

8,998

213,764

9 %

255,757

15,098

270,855

16 %

Special Purpose

86,953

61,678

148,631

6 %

78,120

56,977

135,097

8 %

Recreational Vehicle Parks

13,380

52,003

65,383

3 %

—

—

—

0 %

Self Storage Facilities

—

87,590

87,590

4 %

—

—

—

0 %

Other

49,203

48,373

97,576

4 %

39,820

54,792

94,612

6 %

Total commercial real
estate

$

642,201

$

1,820,825

$

2,463,026

100 %

$

533,842

$

1,156,308

$

1,690,150

100 %

 

NB BANCORP, INC.

NON-GAAP RECONCILIATION

(Unaudited)

(Dollars in thousands)

For the Three Months Ended

June 30, 2026

March 31, 2026

June 30, 2025

Net income (GAAP)

$

21,123

$

14,984

$

14,579

Add (Subtract):

Adjustments to net income:

Non-recurring fees for business line expansion

649

500

–

BOLI surrender tax and modified endowment contract penalty

27

50

64

Merger and acquisition expenses

296

534

530

Total adjustments to net income

$

972

$

1,084

$

594

Less net tax benefit associated with pre-tax non-GAAP adjustments to net income

218

277

130

Non-GAAP adjustments, net of tax

754

807

464

Operating net income (non-GAAP)

$

21,877

$

15,791

$

15,043

Weighted average common shares outstanding, basic

39,693,140

40,969,748

37,191,460

Weighted average common shares outstanding, diluted

40,000,305

41,421,002

37,550,409

Operating earnings per share, basic (non-GAAP)

$

0.55

$

0.39

$

0.40

Operating earnings per share, diluted (non-GAAP)

$

0.55

$

0.38

$

0.40

Pre-tax income (GAAP)

$

27,494

$

20,352

$

18,719

Add (Subtract):

Adjustments to pre-tax income:

Non-recurring fees for business line expansion

649

500

–

Merger and acquisition expenses

296

534

530

Total adjustments to pre-tax income

945

1,034

530

Operating pre-tax income (non-GAAP)

$

28,439

$

21,386

$

19,249

Net interest income (GAAP)

$

69,145

$

64,868

$

47,007

Subtract (Add):

Adjustments to net interest income:

Purchase accounting adjustments

1,972

1,623

–

Total impact of non-GAAP interest net income adjustments

$

1,972

$

1,623

$

–

Net interest income, excluding purchase accounting adjustments (non-GAAP)

$

67,173

$

63,245

$

47,007

Noninterest expense (GAAP)

$

44,017

$

42,701

$

29,405

Subtract (Add):

Adjustments to noninterest expense:

Non-recurring fees for business line expansion

649

500

–

Merger and acquisition expenses

296

534

530

Total impact of non-GAAP noninterest expense adjustments

$

945

$

1,034

$

530

Operating noninterest expense (non-GAAP)

$

43,072

$

41,667

$

28,875

Operating net income (non-GAAP)

$

21,877

$

15,791

$

15,043

Average assets

7,241,524

6,975,068

5,179,324

Operating return on average assets (non-GAAP)

1.21 %

0.92 %

1.16 %

Average shareholders’ equity

$

844,443

$

861,505

$

745,670

Operating return on average shareholders’ equity (non-GAAP)

10.39 %

7.43 %

8.09 %

Operating noninterest expense (non-GAAP)

$

43,072

$

41,667

$

28,875

Total pre-provision net revenue (net interest income plus total noninterest income)

74,704

69,381

51,285

Operating efficiency ratio (non-GAAP)

57.66 %

60.06 %

56.30 %

Income tax expense (GAAP)

$

6,371

$

5,368

$

4,140

Add (Subtract):

Adjustments to income tax expense:

Net tax benefit associated with pre-tax non-GAAP adjustments to net income

218

277

–

BOLI surrender tax and modified endowment contract penalty

(27)

(50)

(64)

Total impact of non-GAAP income tax expense adjustments

$

191

$

227

$

(64)

Operating income tax expense (non-GAAP)

$

6,562

$

5,595

$

4,076

Operating effective tax rate (non-GAAP)

23.1 %

26.2 %

21.2 %

As of

June 30, 2026

March 31, 2026

June 30, 2025

Total shareholders’ equity (GAAP)

$

842,002

$

842,778

$

737,122

Subtract:

Intangible assets (core deposit intangible, net of tax and goodwill)

31,023

32,067

782

Total tangible shareholders’ equity (non-GAAP)

810,979

810,711

736,340

Total assets (GAAP)

7,446,880

7,226,649

5,226,618

Subtract:

Intangible assets (core deposit intangible, net of tax and goodwill)

31,023

32,067

782

Total tangible assets (non-GAAP)

$

7,415,857

$

7,194,582

$

5,225,836

Tangible shareholders’ equity / tangible assets (non-GAAP)

10.94 %

11.27 %

14.09 %

Total common shares outstanding

43,818,490

44,765,178

40,748,380

Tangible book value per share (non-GAAP)

$

18.51

$

18.11

$

18.07

 

NB BANCORP, INC.

ASSET QUALITY – NON-PERFORMING ASSETS (1)

(Unaudited)

(Dollars in thousands)

June 30, 2026

March 31, 2026

June 30, 2025

Real estate loans:

One-to-four-family residential

$

2,963

$

1,763

$

3,030

Home equity

1,547

1,673

1,368

Commercial real estate

957

394

1,984

Construction and land development

–

10

10

Commercial and industrial

20,446

38,885

4,558

Consumer

1,747

2,838

1,528

Total

$

27,660

$

45,563

$

12,478

Total non-performing loans to total loans

0.43 %

0.73 %

0.27 %

Total non-performing PCD loans to total loans (2)

0.22 %

0.49 %

0.00 %

Total non-performing non-PCD loans to total loans

0.21 %

0.24 %

0.27 %

Total non-performing assets to total assets

0.37 %

0.63 %

0.24 %

Total non-performing PCD assets to total assets

0.19 %

0.42 %

0.00 %

Total non-performing non-PCD assets to total assets

0.18 %

0.21 %

0.24 %

(1)

Non-performing loans and assets are comprised of non-accrual loans.

(2)

PCD loans were the result of the BankProv acquisition closed on 11/15/25 and did not exist prior to that date.

 

NB BANCORP, INC.

ASSET QUALITY – PROVISION, ALLOWANCE, AND NET (CHARGE-OFFS) RECOVERIES

(Unaudited)

(Dollars in thousands)

For the Three Months Ended

June 30, 2026

March 31, 2026

June 30, 2025

Allowance for credit losses at beginning of the period

$

80,195

$

87,411

$

38,338

Provision for credit losses

2,994

6,382

4,244

Charge-offs:

One-to-Four-Family Residential

—

(56)

—

Commercial & Industrial

(294)

(12,370)

—

Consumer

(2,081)

(1,409)

(1,190)

Commercial real estate

(10)

—

—

Total charge-offs

(2,385)

(13,835)

(1,190)

Recoveries of loans previously charged off:

Commercial and industrial

1,188

12

12

Commercial real estate

—

—

923

Consumer

96

225

274

Total recoveries

1,284

237

1,209

Net charge-offs

(1,101)

(13,598)

19

Allowance for credit losses at end of the period

$

82,088

$

80,195

$

42,601

Allowance to non-performing loans

297 %

176 %

341.4 %

Allowance to total loans outstanding at the end of the period

1.28 %

1.29 %

0.94 %

Annualized net charge-offs to average loans outstanding during the period

(0.07) %

(0.91) %

0.00 %

Annualized net charge-offs to average loans outstanding during the period – PCD loans (1)

0.00 %

(0.82) %

0.00 %

Annualized net charge-offs to average loans outstanding during the period – Non-PCD loans

(0.07) %

(0.08) %

0.00 %

(1)

PCD loans were the result of the BankProv acquisition closed on 11/15/25 and did not exist prior to that date.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/nb-bancorp-inc-reports-second-quarter-2026-financial-results-declares-quarterly-cash-dividend-302832578.html

SOURCE Needham Bank

Continue Reading

Technology

Vertical IQ Will Expand Industry Intelligence Platform with Small Business Financial Exchange (SBFE) Small Business Credit Data

Published

on

By

RALEIGH, N.C., Oct. 27, 2026 /PRNewswire/ — Small Business Financial Exchange (SBFE), the trusted source for small business lending data and Vertical IQ, a nationally recognized provider of Industry Intelligence, today announced their partnership. Through the partnership, Vertical IQ will incorporate SBFE small business credit insights into its platform, providing financial institutions with deeper context to support commercial lending decisions.

The collaboration enables banks, credit unions, and other commercial lenders using Vertical IQ to gain access to SBFE small business credit insights within the Industry Intelligence platform. Default rates, delinquencies, and credit trends by industries are just a few of the SBFE features that will be included. These insights allow financial services professionals to better understand small business borrowers and support key commercial lending activities.

“At SBFE, we’re committed to helping lenders better understand and support small businesses. Extending access to SBFE insights through Vertical IQ is another way we can deliver value to the lending community and support greater access to capital.”

     – Elisabeth MacDonald, President and CEO, SBFE

“At Vertical IQ, we believe financial institutions make their best decisions when they have access to trusted, Verified Industry Intelligence powered by the highest-quality data available,” said Bobby Martin, co-founder and CEO of Vertical IQ. “Our partnership with SBFE represents another important step in that commitment by bringing highly respected small business credit insights into our platform. By combining SBFE’s credit data with Vertical IQ’s industry expertise, we’re helping lenders gain deeper context to strengthen credit analysis, improve risk assessment, and make more confident decisions throughout the commercial lending lifecycle.”

     – Bobby Martin, Co-founder and CEO, Vertical IQ

About SBFE

SBFE is the trusted data exchange where the small business lending industry comes together to strengthen access to capital for America’s small businesses. For more than 25 years, SBFE has united lenders in a member-driven community built on trust, collaboration, and the responsible use of data. Today, SBFE securely manages one of the nation’s largest repositories of small business credit data, contributed by more than 140 member institutions, including many of the country’s largest commercial banks. This data enables highly predictive credit reporting and portfolio management solutions that help lenders make more informed decisions, manage risk, and support the financial health and growth of small businesses. By transforming shared data into trusted lending intelligence, SBFE helps its members strengthen credit decisioning and promote greater access to capital. Learn more at www.SBFE.org

About Vertical IQ

Headquartered in Raleigh, North Carolina, Vertical IQ is a nationally recognized provider of Industry Intelligence. Whether discussing cash management with a local brewery or evaluating risk for a large manufacturing company, successful banks, credit unions, accounting firms, insurance organizations, and advisory firms use Vertical IQ to better understand a prospect’s or client’s business challenges before, during, and after meetings. Covering 100% of the industries that comprise the U.S. and Canadian economies, as well as more than 3,400 local economic reports, Vertical IQ equips professionals with the confidence and credibility to build stronger client relationships and make more informed decisions. Learn more at www.verticaliq.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/vertical-iq-will-expand-industry-intelligence-platform-with-small-business-financial-exchange-sbfe-small-business-credit-data-302920872.html

SOURCE SBFE

Continue Reading

Technology

CME Group Brazilian Real Futures Set New Daily Volume Record Following Election

Published

on

By

Record $9 billion notional traded, eleven times the year-to-date average daily volume (ADV) as market participants turned to CME Group to manage risk around the clock

CHICAGO, Oct. 27, 2026 /PRNewswire/ — CME Group, the world’s leading derivatives marketplace, today announced that its Brazilian real (BRL) futures reached a new daily volume record of 498,498 contracts (R$49.8 billion, ~$9.2 billion notional value) on October 26, surpassing the previous record of 191,325 contracts (~$3.7 billion notional value) traded on September 28, 2026.

“Following the results of the Brazilian presidential election, clients turned to our BRL futures market to immediately manage their risk outside of Brazilian trading hours, driving all-time record volume,” said Paul Houston, Global Head of FX Products, CME Group. “Even before the onshore market opened, $2.5 billion in notional value had already traded, roughly three times the year-to-date ADV for BRL futures. With liquidity in all timezones and contracts denominated in USD, our markets are fast becoming the main venue for Brazilian real price discovery and trading outside of onshore hours, giving global participants the liquidity they need around the clock.”

In the first half of 2026, Mexican peso and Brazilian real futures and options saw a record combined average daily volume of $2.94 billion.

For more information on CME Group BRL futures, please visit https://www.cmegroup.com/articles/faqs/latam-fx-futures-frequently-asked-questions.html

As the world’s leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals.  The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform.  In addition, it operates one of the world’s leading central counterparty clearing providers, CME Clearing. 

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc.  CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc.  NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc.  COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec Americas LLC and EBS is a trademark of EBS Group LTD. The S&P 500 Index is a product of S&P Dow Jones Indices LLC (“S&P DJI”). “S&P®”, “S&P 500®”, “SPY®”, “SPX®”, US 500 and The 500 are trademarks of Standard & Poor’s Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners. 

CME-G 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cme-group-brazilian-real-futures-set-new-daily-volume-record-following-election-302920902.html

SOURCE CME Group

Continue Reading

Technology

Vera Health Quietly Became One of the World’s Most Used Clinical Tools. Now It Has Raised $32 Million to Give Every Clinician in the World the Best Medical Knowledge in Seconds

Published

on

By

With a team of just 12 employees, the clinical AI company has grown largely through physician referrals, bringing total funding to $32 million

More than 800,000 clinicians across 190 countries use Vera Health, including approximately 1 in 4 physicians in Spain and Italy, with most discovering the platform through recommendations from colleagues.Threshold Ventures led Vera Health’s $28.5 million Series A, with participation from Mantis VC and SV Angel. Existing investors Y Combinator and Gradient tripled down, bringing total funding to $32 million.The investment will accelerate Vera Health’s evidence-focused clinical AI platform, expanding its ability to make global medical knowledge locally relevant and deepening partnerships with medical societies, publishers and health systems.

SAN FRANCISCO, Oct. 27, 2026 /PRNewswire/ — A year ago, a few thousand clinicians were using Vera Health. Today, more than 800,000 are, most having discovered the platform through a colleague. Every month since June, Vera has been the most downloaded clinical app in the world across the App Store and Google Play.¹ In September alone, it was downloaded more times than OpenEvidence and Doximity combined, while monthly downloads had more than tripled since February. With a team of just 12 employees, Vera has reached clinicians in 190 countries, including approximately 1 in 4 physicians in Spain and Italy, largely through word of mouth. Vera Health is a clinical AI search engine that reasons like a clinician, helping physicians find and evaluate medical evidence in seconds.

Today, Vera Health announced a $28.5 million Series A led by Threshold Ventures, with participation from Mantis VC and SV Angel. Existing investors Y Combinator and Gradient, tripled down in the round, bringing the company’s total funding to $32 million. The investment will accelerate Vera Health’s mission to close the gap between what medicine knows and what every patient receives.

Only a few months after raising its Series A, Vera already has more daily active users than it had monthly active users at the time of the raise. Clinicians went from asking Vera a few thousand questions a day to asking hundreds of thousands, every single day.

“Clinicians are the best data scientists I’ve ever met. They make the call in seconds, with more evidence than any human could ever read,” said Taieb Bennani, Co-Founder of Vera Health. “The secret to building for them is to live and breathe the problem like no one else. Everyone on our team is a clinician, or the child or sibling of one, like Maxime and me. That passion translates into every detail of the product, and when you build with that kind of obsession, the product speaks for itself, and clinicians share it with their colleagues. We don’t have the biggest team or the most money. We have the people who care the most about getting it right.”

How does Vera Health differ from general-purpose AI tools?
Clinical AI is increasingly being used to help physicians navigate complex medical questions, but the ability to generate an accurate-sounding answer does not necessarily establish whether the underlying research is reliable. Medicine now publishes a new scientific paper roughly every 20 seconds. Chatbots are built to sound confident. Vera is built to be accurate, and honest when the evidence is thin. Physicians are expected to keep up with an expanding body of research while interpreting guidelines, evaluating treatment options and making decisions for individual patients, sometimes within seconds.

Vera Health finds the evidence first, then writes the answer. Its technology searches more than 60 million peer-reviewed publications, clinical guidelines, consensus statements and drug labels, evaluating sources based on study design, level of evidence, cohort size, recency, journal quality and citation impact. Every claim is linked to its supporting research and color-coded to show the strength of the available evidence. Sometimes that color is red. A rare condition may have no large randomized trial or comprehensive guideline behind it, leaving only a small case series or a report involving a single patient. Vera Health surfaces that research while making its limitations visible, allowing physicians to assess how much weight the findings deserve.

“Medical knowledge moves too quickly for any one clinician to read, and general-purpose AI tools can make uncertain evidence sound settled,” said Maxime Allouch, co-founder, Vera Health. “Unlike other tools, we believe there’s value in making uncertainty visible. The grade shapes what Vera retrieves and writes, while the clinician brings the patient, the context and the judgment.”

Vera Health developed its approach alongside physicians who evaluate medical evidence and help write the guidelines other clinicians follow. Through its partnership with the American College of Emergency Physicians (ACEP), the platform integrates ACEP clinical policies with source attribution, bringing medical society guidance directly into clinical research workflows.

“In medicine, not all evidence is equal,” said Scott M. Silvers, MD, FACEP, Chair of the American College of Emergency Physicians’ Clinical Policies Committee and former Chair of Emergency Medicine at Mayo Clinic. “A large, randomized trial and a case report should never carry the same weight, yet most AI tools blend them into the same confident answer. Level of evidence is the foundation of every guideline we write, and Vera Health is built on it.”

For Dr. Bernard P. Chang, Vera Health’s Chief Scientific Advisor and Vice Chair of Research in the Department of Emergency Medicine at Columbia University, the importance of clinical evidence extends to how physicians evaluate patients.

“On a recent emergency-department shift, I saw a young woman with cough and shortness of breath. The symptoms could easily be attributed to a routine respiratory illness,” said Chang. “Vera Health surfaced evidence that raised my concern for pulmonary embolism, a potentially life-threatening blood clot in the lungs, and led me to broaden my evaluation. What interests me isn’t AI simply providing an answer. It’s whether it can reliably surface evidence that challenges our initial assumptions and improves clinical reasoning. That’s what we’re now evaluating rigorously, inside the academic medical centers where medicine is actually practiced.”

Vera Health’s clinical advisors also include Christopher Baugh, MD, MBA, FACEP, Vice Chair of Clinical Affairs in Emergency Medicine at Brigham and Women’s Hospital and Associate Professor of Emergency Medicine at Harvard Medical School. Its clinical council includes physician leaders affiliated with Mayo Clinic, Yale, Harvard, Columbia and Penn.

Why is Vera Health growing so quickly across international markets?
Bennani and Allouch grew up in families of physicians and initially developed Vera Health for their own fathers. What began with two users has since grown into a platform serving hundreds of thousands of clinicians, with physicians asking hundreds of thousands of questions each day. The company’s international growth reflects an approach built around a central reality of medicine. Medical knowledge is global, but clinical practice is local.

An emergency physician in France may follow different treatment guidelines than a physician in the United States. An oncologist reviewing a complex case may need an exhaustive evaluation of the available research, while an emergency physician needs a concise answer within seconds. Even physicians practicing the same specialty may follow different protocols depending on their institution.

Vera Health accounts for those differences by prioritizing locally relevant guidance while drawing on medical research from around the world. Through Vera Spaces, health systems can also integrate their own clinical protocols and pathways alongside national guidelines and international medical literature.

“Medicine is global, yet most tools in our space were built for a single geography,” said Allouch. “We went international from day one, because only a global view reveals what is truly local.”

The approach has helped Vera Health expand across Europe, where approximately 1 in 4 physicians in Spain and Italy and 1 in 7 in France use the platform, according to company data. Vera Health has achieved that international reach with a small team and a product that clinicians have largely discovered through their peers.

What will Vera Health’s Series A funding support next?
The financing will support further development of Vera Health’s clinical evidence infrastructure, expansion into additional healthcare markets and deeper partnerships with medical societies, publishers and health systems. The company will continue investing in locally relevant clinical guidance and tools that allow healthcare institutions to incorporate their own medical knowledge into the platform.

“In healthcare, trust is earned, not bought. Vera’s adoption among clinicians worldwide speaks to what Taieb and Maxime have built. By combining the most rigorous medical evidence with an understanding of each physician’s specialty, protocols and practice context, Vera makes the world’s medical knowledge relevant to how care is actually delivered. We believe that creates an enormous opportunity to improve global health,” said Andrew Brackin, Partner at Gradient.

“Vera is compelling because it starts with the evidence, not just an answer—helping clinicians find and assess the research behind a decision while making its strengths and limitations visible. By bringing that evidence to the point of care, Vera becomes a trusted clinical intelligence layer, not just another AI tool,” said Emily Melton, co-founder and managing partner of Threshold Ventures.

Vera Health will remain free for licensed clinicians and medical trainees worldwide as it expands access to medical evidence and locally relevant clinical guidance.

New medical knowledge takes an estimated 17 years to reach routine clinical practice, according to research published in the Journal of the Royal Society of Medicine. Vera Health aims to reduce the time physicians spend searching for and evaluating that knowledge, bringing relevant evidence closer to the moment clinical decisions are made.

“Our mission is to close the gap between what medicine knows and what every patient receives,” said Bennani. “Today, that gap is measured in years. We want it measured in seconds.”

About Vera Health
Vera Health is the search engine that reasons like a clinician, finding and grading evidence before showing the source, strength and limits behind every answer. More than 800,000 clinicians in 190 countries use Vera, which is free for licensed clinicians and trainees, never trains on clinicians’ questions, and is HIPAA and GDPR compliant and SOC 2 Type II certified. Founded in 2024 at Y Combinator by MIT graduates and sons of physicians Taieb Bennani and Maxime Allouch, Vera is headquartered in San Francisco and backed by Threshold Ventures, Gradient, Y Combinator, SV Angel and Mantis VC.

Learn more at verahealth.ai.

¹ Download data: Appark, worldwide App Store and Google Play downloads, June through [September] 2026.

Media Contact
Interdependence
(949) 259-6377 x 225
425709@email4pr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/vera-health-quietly-became-one-of-the-worlds-most-used-clinical-tools-now-it-has-raised-32-million-to-give-every-clinician-in-the-world-the-best-medical-knowledge-in-seconds-302920905.html

SOURCE Vera Health

Continue Reading

Trending